Dr. Melody Rene Vander Straten, MD

Dr. Vander Straten practices at Epiphany Dermatology PA in Austin, Texas.

Dr. Vander Straten's NPI, 1730151549, was assigned on February 6, 2006. Dr. Vander Straten graduated from Texas A&M College of Medicine - Bryan in 1994. Dr. Vander Straten holds Texas license M1393.

Dr. Vander Straten's primary practice is Epiphany Dermatology PA, at 7300 Ranch Rd 2222, Austin, TX 78730 in Travis County. The practice phone is (254) 537-1265.

Dr. Vander Straten's primary practice is Epiphany Dermatology PA in Austin, Texas. The medical group on file is Epiphany Dermatology. Dmand AI also links Dr. Vander Straten to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vander Straten practices. Vendor and product names are available with a free account.

Dermatology is Dr. Vander Straten's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Vander Straten is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Vander Straten's licenses on file in 3 states: Texas, Ohio and Georgia.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection, hives and itchy rashes among the conditions Dr. Vander Straten treats.

CMS data shows 5,144 Medicare services from Dr. Vander Straten across 17 procedure codes in 2024, for 947 Medicare patients. Medicare paid $165,757 for them. Every service was in an office.

CMS counts 947 Medicare patients who saw Dr. Vander Straten in 2024. The largest group is 65 to 74, with 525 patients. 75% of them have high cholesterol, and 65% have high blood pressure. Their average risk score is 0.82, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Vander Straten's median patient age at 70, with 61% women.

In 2024, Dr. Vander Straten wrote 1,125 Medicare Part D claims for 480 patients. 96% of them were for generic drugs. CMS names the drug for 985 of them, across 21 drugs with 11 or more claims each, at $80,046 in total drug cost. In 2023, CMS named 851 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Vander Straten for performance year 2024, reported as part of a group. Dr. Vander Straten accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,883 procedures of removal of skin lesions by Dr. Vander Straten, more than 97% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Vander Straten.

CMS Open Payments shows 117 general payments to Dr. Vander Straten from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Novartis Pharmaceuticals Corporation paid the most, $265.

Dr. Vander Straten graduated from Texas A&M College of Medicine - Bryan in 1994.

Dr. Vander Straten is in network with 24 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.